Loading...
Loading...
NextGen
Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality
Systems, Inc.
QSII and a leading provider of healthcare
information systems and connectivity solutions, announced today it has
entered into an agreement with Nipro Diagnostics, Inc. to integrate its
TRUEresult blood glucose monitoring system into the NextGen®
Ambulatory EHR.
This partnership provides NextGen Ambulatory EHR users instant access to
data points captured by patients at home who are using the Nipro
TRUEresult blood glucose monitoring system. Physicians will gain an
immediate benefit from seamlessly performing diagnostic tests with
direct entry of information into a patient's chart. This eliminates the
need to manually re-enter patient data while streamlining
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in